Apogee Therapeutics Stock Quote APGE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

58.635

Bid

58.51

Ask

58.77

Volume

154,529

55.92 Day's Range 59.01

14.19 52 Week Range 72.29

Market Cap

3.429B

Previous Close

59.92

Open

57.00

Last Trade

58.645

Last Trade Time

11:53:40

Financial Volume

$ 8,976,156

VWAP

58.0872

Average Volume (3m)

422,880

Shares Outstanding

58,485,705

Dividend Yield

PE Ratio

-40.83

Earnings Per Share (EPS)

-1.44

Revenue

Net Profit

-83.99M

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.apogeetherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Apogee Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker APGE. The last closing price for Apogee Therapeutics was $59.92. Over the last year, Apogee Therapeutics shares have traded in a share price range of $ 14.19 to $ 72.29.

Apogee Therapeutics currently has 58,485,705 shares outstanding. The market capitalization of Apogee Therapeutics is $3.50 billion. Apogee Therapeutics has a price to earnings ratio (PE ratio) of -40.83.

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases

Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2025 Initiation of the first clinical trial of APG777 and APG990 combination expected to commence in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	7.995	15.7879146919	50.64	60.82	49.74	766465	57.21421224	CS
4	11.275	23.8070101351	47.36	60.82	46.09	497406	52.48170844	CS
12	20.065	52.0222971221	38.57	60.82	36.6	422880	48.08144558	CS
26	-10.205	-14.8242300988	68.84	70.5599	36.26	450845	48.77750978	CS
52	37.835	181.899038462	20.8	72.29	14.19	459817	44.84152252	CS
156	37.135	172.720930233	21.5	72.29	14.19	444310	41.68979328	CS
260	37.135	172.720930233	21.5	72.29	14.19	444310	41.68979328	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OCTOEightco Holdings Inc	$ 3.9077 (56.94%)	88.33M
RZLVRezolve AI Ltd	$ 7.15 (45.33%)	1.14M
SBCSBC Medical Group Holdings Incorporated	$ 9.50 (43.29%)	1.25M
CAPRCapricor Therapeutics Inc	$ 12.03 (32.20%)	19.13M
TNONTenon Medical Inc	$ 5.2099 (29.60%)	18.78M
VTNRVertex Energy Inc	$ 0.137 (-62.05%)	25.25M
CMCTCreative Media and Community Trust Corporation	$ 0.7401 (-52.71%)	1.8M
SFIXStitch Fix Inc	$ 2.415 (-35.60%)	9.8M
BNZIBanzai International Inc	$ 5.41 (-34.34%)	2.17M
SHOTWSafety Shot Inc	$ 0.23 (-28.13%)	8.8k
NVDANVIDIA Corporation	$ 123.86 (2.47%)	147.9M
CEROCERo Therapeutics Holdings Inc	$ 0.1006 (7.36%)	104.18M
MLGOMicroAlgo Inc	$ 0.2514 (16.28%)	89.78M
OCTOEightco Holdings Inc	$ 3.905 (56.83%)	88.33M
SQQQProShares UltraPro Short QQQ	$ 7.4501 (-2.61%)	64.23M